MARKET NEWS

PromoCell Receives EXCiPACT Certification as Manufacturer of Pharmaceutical Excipients to GMP Standards
Vaxart Announces Additional Preclinical COVID-19 Oral Vaccine Data & Publication
Entasis Therapeutics Announces Sulbactam-Durlobactam Expanded Access Program for Patients in the US
DURECT Corporation Announces First Patient Dosed in Phase 2b AHFIRM Study
Antios Therapeutics Completes Phase 1b Clinical Trial of Active Site Polymerase Inhibitor Nucleotide
Ajinomoto Bio-Pharma Services & Humanigen Expand Manufacturing Agreement to Support Fill Finish for Investigational COVID-19 Therapeutic

  FEATURED EDITORIAL

  COMPANY PROFILE

Established in 1949, Stevanato Group is the world’s largest, privately owned designer and producer of glass containers for the pharmaceutical industry. From its outset, the Group has developed its own glass-converting technology to ensure the highest standards of quality. The Group comprises a wide set of capabilities dedicated to serving the biopharmaceutical and diagnostic industries: from glass containers with its historical brand Ompi, to high-precision plastic diagnostic and medical components, to contract manufacturing for drug delivery devices, to vision inspection systems, assembly, and packaging equipment. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Cerba Research Announces Time-Saving COVID-19 Exploratory Tools & NGS Advancements

Cerba Research Announces Time-Saving COVID-19 Exploratory Tools & NGS Advancements

Cerba Research recently announced it has developed two new COVID-19 exploratory tools to enhance clinical research for the development of vaccines and treatments for COVID-19 and other infectious diseases…..

Pacira BioSciences Announces Equity Investment in GeneQuine Biotherapeutics

Pacira BioSciences Announces Equity Investment in GeneQuine Biotherapeutics

Pacira BioSciences, Inc. recently announced that the company will lead an equity investment in GeneQuine Biotherapeutics GmbH…..

Relief Therapeutics & Acer Therapeutics Sign Option Agreement for Exclusivity to Negotiate a Collaboration & License Agreement

Relief Therapeutics & Acer Therapeutics Sign Option Agreement for Exclusivity to Negotiate a Collaboration & License Agreement

Relief Therapeutics Holding AG and Acer Therapeutics Inc. recently announced the companies have signed an Option Agreement providing exclusivity for the right to negotiate a potential collaboration and license….

Agenus Enters Clinical Collaboration With Nelum for Zalifrelimab Combination

Agenus Enters Clinical Collaboration With Nelum for Zalifrelimab Combination

Agenus Inc. recently announced that it has entered into a clinical collaboration with Nelum Corp. to evaluate the safety and efficacy of zalifrelimab, Agenus’ anti-CTLA-4 antibody….

Stevanato Group Launches After-Sales Service Offering for Technologies & Manufacturing Equipment by Establishing a Global Network

Stevanato Group Launches After-Sales Service Offering for Technologies & Manufacturing Equipment by Establishing a Global Network

Stevanato Group has launched an updated comprehensive, global after-sales service offering for pharmaceutical customers. Effective from January this year,….

Credence MedSystems Receives Strategic Investment From Novartis

Credence MedSystems Receives Strategic Investment From Novartis

Credence MedSystems recently announced that Novartis has made a strategic investment in the company. The investment will advance ongoing development and scaling of Credence’s innovative drug delivery systems….

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

February 10 – Injection Devices
February 17 – Formulation Development